Neogenomics (NEO) Acquisitions (2014 - 2025)

Neogenomics (NEO) posted Acquisitions of $463000.0 for Q3 2025, down 99.89% quarter-over-quarter from $419.4 million in Q2 2021.

Neogenomics (NEO) Acquisitions (2014 - 2025) Analysis & Trends

Neogenomics (NEO) has reported Acquisitions for 4 consecutive years, with $463000.0 the latest figure, recorded in Q3 2025.

Acquisitions for Q3 2025 came in at $463000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $463000.0 (changed N/A YoY), and the FY2025 annual result was $6.5 million, changed N/A from the prior year.
Acquisitions was $463000.0 for Q3 2025 at Neogenomics, down from $419.4 million in the prior quarter.
Over five years, Acquisitions peaked at $419.4 million in Q2 2021 and troughed at $463000.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Waters	31,055.11 Bn	31,054.65 Bn	1.11 Bn	144.00 Mn
2	Thermo Fisher Scientific	191.02 Bn	187.77 Bn	7.74 Bn	8.87 Bn
3	Danaher	137.16 Bn	131.47 Bn	3.59 Bn	-
4	Idexx Laboratories	42.82 Bn	42.62 Bn	722.74 Mn	-
5	Natera	39.09 Bn	37.99 Bn	696.04 Mn	-
6	Agilent Technologies	37.61 Bn	35.81 Bn	990.00 Mn	-
7	Iqvia Holdings	34.23 Bn	32.25 Bn	1.36 Bn	37.00 Mn
8	Illumina	28.14 Bn	26.98 Bn	721.00 Mn	415.00 Mn
9	Mettler Toledo International	26.40 Bn	26.33 Bn	555.82 Mn	2.24 Mn
10	Neogenomics	1.93 Bn	1.79 Bn	80.86 Mn	-

Download Data